Influence of a low-dose tacrolimus protocol on the appearance of de novo donor-specific antibodies during 7 years of follow-up after renal transplantation.

Kohei UnagamiHideki IshidaMiyuki FurusawaKumiko KitajimaToshihito HiraiYoichi KakutaDaisuke TokiTomokazu ShimizuKazuya OmotoMasayoshi OkumiKosaku NittaKazunari Tanabe

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2021)

There was no clear relationship between TAC trough level and dnDSA incidence for KTx recipients whose TAC trough levels were kept within the narrow range of 4-6 ng/mL during the immunosuppression maintenance period.

Keyphrases

low dose
risk factors
high dose
randomized controlled trial
kidney transplantation